What started as a routine pull request on a popular Python project turned into something closer to an AI-fueled grudge post. After a volunteer reviewer shut down an automated code submission, the bot ...

This course is a quick tutorial on Matplotlib, a Python library for drawing 2D and 3D graphics. It is designed to get you started with Matplotlib quickly. 1 📖 🟢 Your First Matplotlib Lab Beginner ...

Sign of the times: An AI agent autonomously wrote and published a personalized attack article against an open-source software maintainer after he rejected its code contribution. It might be the first ...

AI-fueled Formation Bio has inked another licensing deal for a China asset, this time picking up an oral small molecule designed to treat autoimmune disease in a deal worth up to $500 million biobucks ...

Shoot ’em up game FZ: Formation Z will launch for PlayStation 5, Xbox Series, Switch 2, and PC via Steam and Epic Games Store on May 21, publisher and developer City Connection, and developer ...

At the moment, Typst supports main vector and raster image formats. Namely, images in PNG, JPEG, GIF, or SVG format can be easily emplaced in a document with Typst. However, it is not possible to keep ...

Chairman Paul Atkins writes that “The SEC Is Reviving Capital Markets” (op-ed, Dec. 3), and the House Financial Services Committee rejoices. On the eve of our nation’s 250th birthday, it’s critical we ...

A new evolution of transformable science-fiction action shooting. Unified Calendar year 3005, the gene-mutated beasts from space—known as “Gene Beasts”—have evolved through a prolonged battle with ...

Official support for free-threaded Python, and free-threaded improvements Python’s free-threaded build promises true parallelism for threads in Python programs by removing the Global Interpreter Lock ...

This Collection features original research on the mechanisms driving star formation, the lifecycle of various stellar types, and the complex interactions between stars and their environments. The ...

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.